This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.
Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.
Epoxide hydrolase
From Proteopedia
(Difference between revisions)
| Line 6: | Line 6: | ||
== Disease == | == Disease == | ||
| - | Inhibitors of ''Mycobacterium tuberculosis'' EH such as urea derivatives, are used as anti-tuberculosis drugs. The valpromide inhibitor of EH is used as anti-epileptic drug. | + | Inhibitors of ''Mycobacterium tuberculosis'' EH such as urea derivatives, are used as anti-tuberculosis drugs. The valpromide inhibitor of EH is used as anti-epileptic drug. Soluble EH plays a role in several diseases including cardiovascular ones and is a drug target for their therapy <ref>PMID:19794443</ref>. |
== Relevance == | == Relevance == | ||
Revision as of 21:10, 19 January 2016
| |||||||||||
3D Structures of epoxide hydrolase
Updated on 19-January-2016
References
- ↑ Imig JD, Hammock BD. Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases. Nat Rev Drug Discov. 2009 Oct;8(10):794-805. doi: 10.1038/nrd2875. PMID:19794443 doi:http://dx.doi.org/10.1038/nrd2875
